BiotechTube
Home/EvlaBio/Thomas Kirmeier
TK

Thomas Kirmeier

COO & Co-founder

EvlaBio

Therapeutic Areas

Cardiorenal DiseaseChronic Kidney DiseaseCardiovascular Disease

EvlaBio Pipeline

DrugIndicationPhase
Anti-FGFR4 mAbLeft Ventricular Hypertrophy in Chronic Kidney DiseasePre-clinical

Leadership Team at EvlaBio

WV
Wenzel von der Heydte
CEO & Co-founder
CS
Christian Stegmann
CSO
View full EvlaBio profile